Praesens Care, a start-up based in Belgium, has developed a mobile laboratory with the aim of safely testing people for a wide range of killer diseases. Its mobile laboratories enable monitoring of infectious diseases and improve diagnostic capabilities in remote areas in Africa.

Sanofi Pasteur’s newly approved dengue vaccine, Dengvaxia, was unusual in that it was launched in the Philippines and other at-risk countries. By choosing to “flip the model” – launch in an emerging market setting as opposed to developed markets – it had to overcome various obstacles across the value chain, from registration to financing to supply.

There are few industries in which the effects of technological innovation be seen as clearly as they can in the healthcare industry. Developments in devices, services and networks are in turn creating even more opportunities and innovation. This case looks specifically at developments in Stem Cell-related technologies, and the impact these might have on the treatment of certain diseases.

Technological and scientific innovation in recent years has opened many new lines of research and development in the field of cloning. Developments in agriculture and forestry have brought new approaches and methods in crop and forest production, and many more are predicted to emerge in the coming decade.

Technological and scientific innovation in recent years has opened up much research and development in relation to human cloning. Many early steps have been taken and further progress is anticipated for the coming decade.